Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925343.RAoLuIJQUoq9sQNI79WrscAyGzYSH3t_w2k1mVdXuaOhc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925343.RAoLuIJQUoq9sQNI79WrscAyGzYSH3t_w2k1mVdXuaOhc130_assertion type Assertion NP925343.RAoLuIJQUoq9sQNI79WrscAyGzYSH3t_w2k1mVdXuaOhc130_head.
- NP925343.RAoLuIJQUoq9sQNI79WrscAyGzYSH3t_w2k1mVdXuaOhc130_assertion description "[In vitro, Zyflamend inhibited the proliferation of pancreatic cancer cell lines regardless of p53 status and also enhanced gemcitabine-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925343.RAoLuIJQUoq9sQNI79WrscAyGzYSH3t_w2k1mVdXuaOhc130_provenance.
- NP925343.RAoLuIJQUoq9sQNI79WrscAyGzYSH3t_w2k1mVdXuaOhc130_assertion evidence source_evidence_literature NP925343.RAoLuIJQUoq9sQNI79WrscAyGzYSH3t_w2k1mVdXuaOhc130_provenance.
- NP925343.RAoLuIJQUoq9sQNI79WrscAyGzYSH3t_w2k1mVdXuaOhc130_assertion SIO_000772 21935918 NP925343.RAoLuIJQUoq9sQNI79WrscAyGzYSH3t_w2k1mVdXuaOhc130_provenance.
- NP925343.RAoLuIJQUoq9sQNI79WrscAyGzYSH3t_w2k1mVdXuaOhc130_assertion wasDerivedFrom befree-2016 NP925343.RAoLuIJQUoq9sQNI79WrscAyGzYSH3t_w2k1mVdXuaOhc130_provenance.
- NP925343.RAoLuIJQUoq9sQNI79WrscAyGzYSH3t_w2k1mVdXuaOhc130_assertion wasGeneratedBy ECO_0000203 NP925343.RAoLuIJQUoq9sQNI79WrscAyGzYSH3t_w2k1mVdXuaOhc130_provenance.